City of Hope, an innovative biomedical research, treatment and educational institution with over 6000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.
Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers that develops and institutes standards of care for cancer treatment.
Postdoctoral positions are now available in the laboratory of Dr. Terence Williams, MD, PhD, Professor and Chair in the Department of Radiation Oncology, Cancer Genetics and Epigenetics within the Beckman Research Institute of City of Hope. Applicants should be highly motivated, creative, independent fast learners, with strong work ethic and critical-thinking abilities, seeking to perform high-impact research and publish in high-impact journals. Dr. Williams’ laboratory seeks a researcher interested in focusing on cancer biology, tumor metabolism, nutrient scavenging, endocytosis, developmental therapeutics, and molecular imaging in multiple cancer types, including lung cancer, pancreatic cancer, thyroid cancer, colorectal cancer, brain tumors, etc. Dr. Williams’ lab was the first to identify a role for caveolae/Cav-1 in albumin uptake and nutrient scavenging, as well as important roles for BRAF and KRAS mutations in response to genotoxic therapies, including radiation. His lab actively studies Caveolin-1 and caveolae-mediated endocytosis as a target for cancer therapy, how oncogenes (e.g. KRAS, BRAF) mediate resistance to therapy, how to harness cell cycle and cell cycle checkpoint repair pathways for therapeutic intent (e.g. Wee1, ATR, Chk1), developing novel RNA-based nanotherapeutics and protein-drug conjugates, and novel RNA-based signatures to predict outcomes and therapeutic response. Dr. Williams’ lab research studies span across cell line modeling, animal modeling (e.g. including transgenic mouse and patient-derived models), to research with human tissues from patients with cancer.
The long-term goals of the research are to better understand the underlying molecular mechanisms of how cancer cells perform nutrient scavenging as well as how oncogenes regulate tumor metabolism, which will hopefully lead to the identification of key molecular targets that engender improvements of therapy in solid tumors. His lab is dedicated to translational research, assessing molecular alterations in cancer models and patient tissues, and obtaining novel insights from the bedside.
Basic education, experience and skills required for consideration:
A Ph.D. degree in life or biomedical sciences, or a related discipline is required.
Proficiency in molecular and cellular biology, biochemistry, cancer biology and/or animal (mouse) studies is required.
Dr. Williams research is currently supported by multiple NIH R01 grants, American Cancer Society grant, Radiation Oncology Institute grant, Florida Biomedical Research Program grant, and institutional funds.
Research findings from Dr. Williams’ research group have been published in Clinical Cancer Research, Cancer Research, Molec Cancer Therapeutics, Oncotarget, J Clin Invest, J Clin Oncology, J Thoracic Oncol, PNAS, Cancer, JAMA Surgery, IJROBP, R&O, J Biol Chem, Molec Biol Cell, Cell Cycle, and numerous other journals.
City of Hope is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.